Oxymetholone Research Overview
Oxymetos Pharmacom contains oxymetholone, a potent anabolic-androgenic steroid compound originally developed for therapeutic applications in clinical medicine. This pharmaceutical-grade formulation provides researchers with a standardised oral tablet form for investigating muscle protein synthesis pathways, nitrogen retention mechanisms, and anabolic signalling cascades in controlled laboratory settings. Research institutions studying muscle wasting conditions utilise oxymetholone to examine its effects on skeletal muscle hypertrophy, myofibrillar protein accumulation, and satellite cell activation in cellular and animal models.
Laboratory investigations at Stroid UK Shop demonstrate oxymetholone’s capacity to modulate various anabolic pathways through its interaction with androgen receptor complexes. Researchers examining therapeutic targets for sarcopenia and cachexia frequently evaluate this compound alongside other oral steroid formulations in their oxymetholone tablet studies. The pharmaceutical manufacturing standards ensure consistent potency across research batches, enabling reliable experimental reproducibility in comparative studies.
Laboratory Applications in Research
Research teams investigating muscle biology utilise Oxymetos Pharmacom to study anabolic steroid mechanisms in various experimental models. Laboratory analyses focus on examining dose-response relationships in muscle protein synthesis, investigating androgenic receptor binding kinetics, and evaluating metabolic effects on nitrogen balance in controlled research environments. Comparative studies often examine oxymetholone alongside selective androgen receptor modulators to understand tissue-selective anabolic effects and receptor specificity differences.
Advanced research protocols examine oxymetholone’s influence on satellite cell proliferation, myonuclear domain expansion, and muscle fiber type composition in preclinical models. Molecular biology laboratories investigate gene expression changes in muscle tissue, particularly focusing on myosin heavy chain isoforms and metabolic enzyme activity. Research teams studying therapeutic applications for muscle wasting diseases evaluate oxymetholone’s potential alongside peptide-based therapeutics in combination therapy protocols.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Oxymetholone |
| Formulation | Oral tablets |
| Manufacturer | Pharmacom Labs |
| Chemical Formula | C₂₁H₃₂O₃ |
| Molecular Weight | 332.48 g/mol |
| CAS Number | 434-07-1 |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
Oxymetos Pharmacom is manufactured exclusively for in-vitro laboratory research applications and educational purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must adhere to institutional safety protocols and regulatory guidelines when handling this compound. All experimental procedures should be conducted under appropriate laboratory supervision with proper safety equipment and waste disposal methods. This product is restricted to qualified research institutions and licensed laboratories for legitimate scientific investigation purposes only.
